ECI bid for Premier Research 

UK mid-market private equity firm ECI Partners (ECI) has made a bid to acquire clinical specialist Premier Research Group (PRG) for £60 million.

The offer is subject to the approval of PRG shareholders.

Headquartered in Berkshire, PRG provides a range of clinical services, including the design and execution of clinical trials, to the pharmaceutical, biotechnology and medical device industries. The company has approximately 850 employees, with 17 operating facilities throughout Western, Central and Eastern Europe and 11 in the US.

ECI Partners’ Richard Chapman comments that the sector PRG operates in ‘is set to continue growing significantly at an estimated ten per cent per annum thanks to the non-cyclical nature of demand for healthcare in general and pharmaceuticals in particular’.

Chapman adds that he expects the company to expand by organic growth and further acquisitions.

Marc Barber

Marc Barber

Marc was editor of GrowthBusiness from 2006 to 2010. He specialised in writing about entrepreneurs, private equity and venture capital, mid-market M&A, small caps and high-growth businesses.

Related Topics

Early Stage Funding